These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33149269)

  • 21. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
    World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine.
    Li J; Zhou Z; Jiang DJ; Li D; Tan B; Liu H; Li YJ
    Clin Exp Hypertens; 2007 Oct; 29(7):489-501. PubMed ID: 17994357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A; Doi S; Mizutani S; Azuma H
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.
    Mizuno S; Ishizaki T; Toga H; Sakai A; Isakova J; Taalaibekova E; Baiserkeev Z; Kojonazarov B; Aldashev A
    Biomed Res Int; 2015; 2015():196904. PubMed ID: 26380264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
    Wilcken DE; Sim AS; Wang J; Wang XL
    Mol Genet Metab; 2007 Aug; 91(4):309-17; discussion 308. PubMed ID: 17560156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADMA, homocysteine and redox status improvement affected by 7-nitroindazole in spontaneously hypertensive rats.
    Dovinová I; Hrabárová E; Jansen E; Kvandová M; Majzúnová M; Berenyiová A; Barančík M
    Biomed Pharmacother; 2018 Oct; 106():1478-1483. PubMed ID: 30119222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia.
    Bekpinar S; Develi-Is S; Unlucerci Y; Kusku-Kiraz Z; Uysal M; Gurdol F
    Can J Physiol Pharmacol; 2013 Dec; 91(12):1071-5. PubMed ID: 24289078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia.
    Mao D; Che J; Li K; Han S; Yue Q; Zhu L; Zhang W; Li L
    Arch Gynecol Obstet; 2010 Oct; 282(4):371-5. PubMed ID: 19806356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.
    Demir B; Demir S; Pasa S; Guven S; Atamer Y; Atamer A; Kocyigit Y
    J Obstet Gynaecol; 2012 Aug; 32(6):525-8. PubMed ID: 22779953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells.
    Jung CH; Lee WJ; Hwang JY; Lee MJ; Seol SM; Kim YM; Lee YL; Kim HS; Kim MS; Park JY
    PLoS One; 2012; 7(12):e52346. PubMed ID: 23284999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine prevents hypertension via regulation of the ADMA-DDAH pathway in young spontaneously hypertensive rats.
    Fan NC; Tsai CM; Hsu CN; Huang LT; Tain YL
    Biomed Res Int; 2013; 2013():696317. PubMed ID: 24455716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD).
    Scott JA; Duongh M; Young AW; Subbarao P; Gauvreau GM; Grasemann H
    Int J Mol Sci; 2014 Apr; 15(4):6062-71. PubMed ID: 24727374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.
    Weinberg JB; Yeo TW; Mukemba JP; Florence SM; Volkheimer AD; Wang H; Chen Y; Rubach M; Granger DL; Mwaikambo ED; Anstey NM
    J Infect Dis; 2014 Sep; 210(6):913-22. PubMed ID: 24620026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
    Sasser JM; Cunningham MW; Baylis C
    Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1355-62. PubMed ID: 25298524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.